Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity

By afschroeder • August 6, 2025

Tsaktanis T, Ammon L, Lößlein L, Peter A, Vandrey O, Naumann UJ, Behne M, Cook LJ, Levy M, Yeaman MR, Bennett JL, Rothhammer V; Guthy-Jackson Charitable Foundation CIRCLES Study Group. Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity. Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200457. doi: 10.1212/NXI.0000000000200457. Epub 2025 Aug 5. PMID: 40763318.

Tags: Harbor UCLA, Infectious Diseases, Publications

Hidradenitis in Pediatrics

Dhillon S, Horneck N, Smogorzewski J. Hidradenitis in Pediatrics. Adv Pediatr. 2026 Aug;73(1):295-307. doi: 10.1016/j.yapd.2025.12.007. Epub 2026 May 21. PMID: 42481098.

Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV

Cindi Z, Cardone KM, Bradford Y, Hall MA, Kim H, Daar ES, Gulick R, Riddler SA, Vujkovic M, Chang KM, Tsao PS, Sinxadi P, Haas[...]

Development and Psychometric Evaluation of the End-Stage Renal Disease Adherence Questionnaire-Short Form: English, Spanish, and Korean Versions

Kim Y, Cho WK, Song J, Evangelista LS, Kopple JD. Development and Psychometric Evaluation of the End-Stage Renal Disease Adherence Questionnaire-Short Form: English, Spanish, and[...]